Cargando…
GMP-grade neural progenitor derivation and differentiation from clinical-grade human embryonic stem cells
BACKGROUND: A major challenge for the clinical use of human pluripotent stem cells is the development of safe, robust and controlled differentiation protocols. Adaptation of research protocols using reagents designated as research-only to those which are suitable for clinical use, often referred to...
Autores principales: | Vitillo, Loriana, Durance, Catherine, Hewitt, Zoe, Moore, Harry, Smith, Austin, Vallier, Ludovic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501686/ https://www.ncbi.nlm.nih.gov/pubmed/32948237 http://dx.doi.org/10.1186/s13287-020-01915-0 |
Ejemplares similares
-
In vitro differentiation of cGMP-grade retinal pigmented epithelium from human embryonic stem cells
por: Lojudice, Fernando H., et al.
Publicado: (2019) -
The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines
por: Canham, Maurice A., et al.
Publicado: (2015) -
Integrin-Associated Focal Adhesion Kinase Protects Human Embryonic Stem Cells from Apoptosis, Detachment, and Differentiation
por: Vitillo, Loriana, et al.
Publicado: (2016) -
Derivation of Xeno-Free and GMP-Grade Human Embryonic Stem Cells – Platforms for Future Clinical Applications
por: Tannenbaum, Shelly E., et al.
Publicado: (2012) -
Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells
por: Ohmine, Seiga, et al.
Publicado: (2011)